The true impact of the altered fetal pancreas transcriptome at mid-gestation, as the result of SLC2A3-RNAi-induced fetal hypoglycemia, awaits thorough physiological assessment later in gestation or postnatally. This evidence concerns the gene SLC2A3 and Hypoglycemia.